Human parvovirus B19-associated disease in bone marrow transplantation

M. Schleuning, G. Jäger, E. Holler, W. Hill, C. Thomssen, C. Denzlinger, T. Lorenz, G. Ledderose, W. Wilmanns, H. J. Kolb

Research output: Contribution to journalArticlepeer-review

47 Scopus citations


Human parvovirus B19 can persist in immunocompromised patients and may produce severe clinical illness. In this retrospective study the incidence of B19-associated infections in bone marrow transplant patients was investigated. During 1 year 60 patients received bone marrow grafts (eight autografts and 52 allogeneic transplantations). In case of early onset, atypical or steroid-resistant erythrodermia the patients' blood and/or tissue specimens were screened for B19 infection by polymerase chain reaction (PCR). Additionally, specimens of patients with severe organ failure were tested. A total of 64 PCRs was performed in 27 patients. Seven patients with erythrodermia and one with vulvovaginitis proved to be PCR positive. In patients with organ failure B19 DNA was detected in the myocardium and liver. The incidence of B19 infections in this cohort was 15% and the B19-associated mortality rate 7%. In conclusion, parvovirus B19-associated infections may be more common in immunocompromised patients than previously anticipated.

Original languageEnglish
Pages (from-to)114-117
Number of pages4
Issue number2
StatePublished - 1999
Externally publishedYes


Dive into the research topics of 'Human parvovirus B19-associated disease in bone marrow transplantation'. Together they form a unique fingerprint.

Cite this